PIK3CA and plasma cell myeloma: Our results showed that CUDC-907 potently inhibited the proliferation of myeloma cell lines at a lower concentration (Fig. 3a) by inhibiting Akt, which is a downstream mediator of PI3K (Fig. 2d).